Global Drug Discovery Market 2022-2028

According to Gen Consulting Company, the global drug discovery market is set to achieve an incremental growth of USD 44 billion, acelerating at a CAGR of almost 8.7% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global drug discovery market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the drug discovery industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, drug type, disease application, end user, and region. The global market for drug discovery can be segmented By type bioanalytical instruments, bioinformatics, cell-based assays and reagents, genomics, high-throughput screening, proteomics, others. The bioanalytical instruments segment was the largest contributor to the global drug discovery market in 2021. Drug discovery market is further segmented By drug type biologics, small-molecule drugs. Based on disease application, the drug discovery market is segmented into: cancer, cardiovascular, immunological, neurological, others. The cancer segment held the largest revenue share in 2021. On the basis of end user, the drug discovery market also can be divided into: academia and research institutes, contractresearch organizations (CROs), pharmaceutical companies. Drug discovery market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By type:
- bioanalytical instruments
- bioinformatics
- cell-based assays and reagents
- genomics
- high-throughput screening
- proteomics
- others

By drug type:
- biologics
- small-molecule drugs

By disease application:
- cancer
- cardiovascular
- immunological
- neurological
- others

By end user:- academia and research institutes
- contractresearch organizations (CROs)
- pharmaceutical companies

By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)

The report also provides analysis of the key companies of the industry and their detailed company profiles including Agilent Technologies Inc., AMETEK, Inc., Arrayit Corp., Becton, Dickinson and Company, Biomax InformaticsAG, Bio-Rad Laboratories, Inc., Bruker Corp., Charles River Laboratories, Inc., Danaher Corp., General Electric Company (GE), Hitachi High-Technologies Corporation, Illumina, Inc., JEOL Ltd., LECO Corporation, Merck KGaA, Perkin Elmer Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global drug discovery market.
- To classify and forecast the global drug discovery market based on type, drug type, disease application, end user, region.
- To identify drivers and challenges for the global drug discovery market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global drug discovery market.
- To identify and analyze the profile of leading players operating in the global drug discovery market.

Why Choose This Report
- Gain a reliable outlook of the global drug discovery market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TYPE
Bioanalytical instruments
Bioinformatics
Cell-based assays and reagents
Genomics
High-throughput screening
Proteomics
Others
PART 6. MARKET BREAKDOWN BY DRUG TYPE
Biologics
Small-molecule drugs
PART 7. MARKET BREAKDOWN BY DISEASE APPLICATION
Cancer
Cardiovascular
Immunological
Neurological
Others
PART 8. MARKET BREAKDOWN BY END USER
Academia and research institutes
Contractresearch organizations (CROs)
Pharmaceutical companies
PART 9. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 10. KEY COMPANIES
Agilent Technologies Inc.
AMETEK, Inc.
Arrayit Corp.
Becton, Dickinson and Company
Biomax InformaticsAG
Bio-Rad Laboratories, Inc.
Bruker Corp.
Charles River Laboratories, Inc.
Danaher Corp.
General Electric Company (GE)
Hitachi High-Technologies Corporation
Illumina, Inc.
JEOL Ltd.
LECO Corporation
Merck KGaA
Perkin Elmer Inc.
Qiagen N.V.
Roche Holding AG
Shimadzu Corporation
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Global Whole Exome Sequencing Market 2023

DescriptionThe Whole Exome Sequencing Market is poised for substantial growth, with a projected increase from USD 1.43 billion in 2022 to USD 3.75 billion by 2029. This growth is expected

USD 1950 View Report

Global Continuous Bioprocessing Market 2023

DescriptionThe global Continuous Bioprocessing Market size is anticipated to expand from USD 133.9 million in 2022 to USD 443.1 million by 2029, registering a compound annual growth rate (CAGR) of

USD 1950 View Report

2024 Global Drugs Abuse Testing Market Assays Supplier Shares

2024 Global Drugs of Abuse Testing Market for 12 Assays--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers This new 318-page

USD 6500 View Report

2024 Global Drug of Abuse Testing Market

2024 Global Drug of Abuse Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 12 Assays, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities for

USD 7500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available